May 15 (Reuters) - Imprimis Pharmaceuticals Inc:
* SURFACE PHARMACEUTICALS, INC. ANNOUNCES $20 MILLION SERIES A FINANCING FROM FLYING L PARTNERS
* IMPRIMIS PHARMACEUTICALS - SURFACE PHARMA INTENDS TO USE PROCEEDS OF FINANCING TO ADVANCE CLINICAL DEVELOPMENT PROGRAMS FOCUSED ON OCULAR SURFACE DISEASE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.